Free Trial

Canopy Growth (TSE:WEED) Hits New 1-Year Low - Should You Sell?

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$2.51 and last traded at C$2.48, with a volume of 736176 shares traded. The stock had previously closed at C$2.68.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on WEED. ATB Capital reduced their price objective on Canopy Growth from C$4.00 to C$3.20 and set an "underperform" rating for the company in a research report on Monday, February 10th. Canaccord Genuity Group dropped their price objective on Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating on the stock in a report on Monday, February 10th. Four investment analysts have rated the stock with a sell rating and one has issued a hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Reduce" and a consensus price target of C$5.64.

Read Our Latest Analysis on WEED

Canopy Growth Stock Performance

The company has a debt-to-equity ratio of 120.38, a quick ratio of 2.32 and a current ratio of 1.39. The company has a market cap of C$371.60 million, a P/E ratio of -0.34, a P/E/G ratio of -0.01 and a beta of 1.79. The firm has a 50 day moving average price of C$3.39 and a 200-day moving average price of C$5.47.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Read More

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Strong Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

As Wall Street's 2025 predictions roll in, Goldman Sachs is focusing on manufacturing, energy, and domestic producers as key sectors for growth.

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines